Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform.
Norbert BanyiDeepu AlexCurtis HughesmanKelly McNeilDiana N IonescuCarmen MaStephen YipBarbara L MeloskyPublished in: Current oncology (Toronto, Ont.) (2022)
Using the Idylla EGFR test as part of the molecular testing repertoire in advanced-stage NSCLC patients could significantly reduce TTT.
Keyphrases
- small cell lung cancer
- advanced non small cell lung cancer
- epidermal growth factor receptor
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- tyrosine kinase
- prognostic factors
- peritoneal dialysis
- high throughput
- dna methylation
- genome wide
- transcription factor
- brain metastases
- genome wide identification
- genome wide analysis